stocks
544738-BOM

Speciality Medicines Ltd.

144.00-5.0 (-3.36%)
23 Oct, 1:59 PM

Stock Scores

Quality Score

69.9 / 100

Value Score

72.8 / 100

Price Momentum Score

18.3 / 100

QVM Score

54.8 / 100

Key Metrics

Market Cap
130.91
P/E (TTM)
10.04
P/B
1.84
P/S (TTM)
1.74
EV/EBITDA
8.26
CAPE (5Y)
23.42
ROE (TTM)
25.60
ROCE (TTM)
23.80
ROA (TTM)
19.27
Avg 3Y ROE
32.17
Earnings 3Y CAGR
97.61
Sales 3Y CAGR
47.96
Sales 5Y CAGR
-
Debt/Equity
0.09
Consensus TP
-
Strong Buy %
-
Promoter Holding
-
Pledged %
-

Share Price

Track Speciality Medicines Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

144.00-5.0 (-3.36%) D
14.38% since 30 Mar 2026
1 Week returns: -15.27 %
Low
140.0
High
170.0
1 Month returns: -2.37 %
Low
140.0
High
210.0
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Speciality Medicines Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 10.04 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -67.39%

What is P/E Ratio?

Median: 30.79
Value 10.04
-0.85654.83
Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative
Weak price momentum

Price Momentum score of 18.3 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

18.3 / 100

Company's earnings are of low quality

Earnings quality score of 22.5 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

22.5 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.20621.

Financial Snapshot

See detailed analysis

Multi-year trends for Speciality Medicines Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00k0k0k0k58.3 CrMar 202575.3 CrMar 2026
Profit After Tax FY
00k0k0k7.2 CrMar 202513.0 CrMar 2026
ROE FY
0%10%20%30%40%30.5%Mar 202525.6%Mar 2026
EBITDA FY
00k0k0k9.1 CrMar 202513.7 CrMar 2026

Speciality Medicines Ltd. Shareholding Pattern

Quarterly breakdown of Speciality Medicines Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Dec 2025Mar 2026
Total Promoter
-
43.43
Indian Promoter
-
43.43
Foreign Promoter
-
-
Institutions
-
0.24
Mutual Funds / UTI
-
-
FI/Bank/Insurance
0.00
0.00
Govt
-
-
FII
0.00
0.24
Other Institutions
0.00
0.00
Non-Institution
-
56.33
Bodies Corporate
-
1.06
Others (incl. Retail)
No. of shareholders
0.00
0
55.27
741

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Speciality Medicines Ltd. shares as reported to NSE and BSE.

NameDateTypePriceQty.Value
Paradise Moon Investment Fund-I04 Jun 2026sell₹ 211.0060.00 k-
Niraj Rajnikant Shah04 Jun 2026sell₹ 210.0050.00 k-
Yash Hitesh Patel29 May 2026buy₹ 207.852.00 lac-
Niraj Rajnikant Shah29 May 2026buy₹ 207.8550.00 k-
Feroza Anwar Shaikh29 May 2026sell₹ 207.851.00 lac-
Bhavna Hitesh Patel29 May 2026sell₹ 225.525.00 k-
Bhavna Hitesh Patel29 May 2026buy₹ 208.4269.00 k-
Anwar Mohammed Shaikh29 May 2026sell₹ 207.901.12 lac-
Ainul Anwar Shaikh29 May 2026sell₹ 207.851.02 lac-
Neo Apex Share Broking Services Llp22 May 2026sell₹ 208.9561.00 k-

No corporate action data available.

Company Profile

Overview of Speciality Medicines Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Speciality Medicines Limited is an India-based pharmaceutical company. The Company is engaged in marketing and distribution of finished formulations of specialty pharmaceuticals. It offers a diverse portfolio of specialty pharmaceuticals, focusing on therapeutic areas such as oncology, immunology, n...
Key personnel
Mr. Kalpesh Bharatbhai Pipaliya
Chief Financial Officer
Ms. Anita Kumawat
Compliance Officer, Company Secretary
Ms. Vandana Siyasharan Vashwakarma
Purchase Executive
Mr. Parthkumar Babulal GoyaniD
Executive Chairman of the Board, Managing Director
Mr. Sumit Babubhai GoyaniD
Whole Time Director
Mr. Bhaveshkumar Ashokbhai SavaniD
Non-Executive Director
Ms. Archana Madhav BhayaniD
Non-Executive Independent Director
Mr. Chandresh M. UnagarD
Non-Executive Independent Director
View all
Incorporated on
05 Feb 2021
Last Annual
31 Mar 2026
Last Interim
-
No. of Employees
25
IPO date
-
Free Float
28,31,314
Phone no.
+912246045344
Address
27, First Floor, Andheri Sainath Industrial Premises Co-op-soc ltd, 20-Mahakali Caves Road, Andheri East, MUMBAI, 400093, India

Frequently Asked Questions

What is the current share price of Speciality Medicines Ltd.?
The current share price of Speciality Medicines Ltd. is ₹ 144.00 as of 23 Oct 2026.
What is the market capitalisation of Speciality Medicines Ltd.?
The market capitalisation of Speciality Medicines Ltd. stands at ₹ 130.91 Cr.
What is the PE ratio of Speciality Medicines Ltd.?
The Price-to-Earnings (PE) ratio of Speciality Medicines Ltd. is 10.04 as of the latest trailing twelve months data.
What is the ROE and ROCE of Speciality Medicines Ltd.?
Speciality Medicines Ltd. has a Return on Equity (ROE) of 25.60% and a Return on Capital Employed (ROCE) of 23.80% as per the latest financial reports.
What is the 52-week high and low of Speciality Medicines Ltd.?
The 52-week high of Speciality Medicines Ltd. is - and the 52-week low is -.
What is the dividend yield of Speciality Medicines Ltd.?
The dividend yield of Speciality Medicines Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Speciality Medicines Ltd.?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Speciality Medicines Ltd. shares.
What sector does Speciality Medicines Ltd. belong to?
Speciality Medicines Ltd. operates in the Healthcare sector.
What is the beta of Speciality Medicines Ltd.?
The beta of Speciality Medicines Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Speciality Medicines Ltd.?
The 14-day Relative Strength Index (RSI) of Speciality Medicines Ltd. is 41.96, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.